ArticleEuropean radiology2013
Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma.
Article in European radiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 34 citations in OpenAlex.
- Machine learning-based radiomics from multiparametric MRI for predicting aggressive pathology in clear cell renal cell carcinoma.BMC medical imaging · 2025Article
- Differential Diagnosis of Type 1 and Type 2 Papillary Renal Cell Carcinoma Based on Enhanced CT Radiomics Nomogram.Frontiers in oncology · 2022Article
- Tumor contour irregularity on preoperative imaging: a practical and useful prognostic parameter for papillary renal cell carcinoma.European radiology · 2021Article
- Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2021Article
- Predicting common solid renal tumors using machine learning models of classification of radiologist-assessed magnetic resonance characteristics.Abdominal radiology (New York) · 2020Article
- Apparent Diffusion Coefficient Distinguishes Malignancy in T1-Hyperintense Small Renal Masses.AJR. American journal of roentgenology · 2020Article
- Imaging Advances in the Management of Kidney Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018Review
- Imaging of Solid Renal Masses.The Urologic clinics of North America · 2018Review
- Imaging of Solid Renal Masses.Radiologic clinics of North America · 2017Review
- Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract.Magnetic resonance imaging clinics of North America · 2016Review
- MRI phenotype in renal cancer: is it clinically relevant?Topics in magnetic resonance imaging : TMRI · 2014Review
- Dual energy MDCT assessment of renal lesions: an overview.European radiology · 2014Review
- Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomography.SpringerPlus · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveTo evaluate the prognostic implications of the MRI appearance and pathological features of papillary renal cell carcinoma (pRCC).
methodsA total of 128 pRCC in 115 patients who underwent preoperative MRI were characterised in terms of pathological type (type 1 vs. type 2), MRI appearance (focal vs. infiltrative) and additional MRI features. Patients were classified on the basis of the presence or absence of metastatic disease.
resultsThere were 65 focal type 1, 54 focal type 2 and 9 infiltrative pRCC. All infiltrative pRCC were of histopathological type 2. Renal vein thrombus was present in 89 % of infiltrative pRCC and no cases of focal pRCC. Metastatic disease was observed in 3.7 % of focal type 1, 7.5 % of focal type 2 and 75.0 % of infiltrative type 2 pRCC. Infiltrative MRI appearance was a significant predictor of metastatic disease, independent of pathological type, size and T stage (P ≤ 0.020). Among focal pRCC on MRI, pathological type 2 was not a significant predictor of metastatic disease (P = 0.648). No combination of features achieved significantly greater accuracy for predicting metastatic disease than renal vein thrombus alone (P > 0.5).
conclusionInfiltrative MRI appearance and renal vein thrombus identify a subset of pathological type 2 pRCC at a significantly increased risk of metastatic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.